Aslan Pharmaceuticals Ltd (NASDAQ:ASLN)
| 0.53 Delayed Data As of Jul 01 |  +0.035 / +7.07%Today’s Change | 0.36 Today|||52-Week Range 3.81 | -52.68% Year-to-Date |
Latest ASLN News | Press Releases
No recent news for Aslan Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 0.50 |
| Today’s open | 0.50 |
| Day’s range | 0.50 - 0.53 |
| Volume | 326 |
| Average volume (3 months) | 238,995 |
| Market cap | $34.9M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -14.12% |
| Earnings growth (this year) | -68.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBOTMicrobot Medical Inc | -0.26 | -5.07% |
| --Zero Gravity Solutio... | 0.00 | 0.00% |
| PNEXFPharnext SA | 0.00 | 0.00% |
| CMMBChemomab Therapeutic... | -0.20 | -5.41% |
Data as of 3:00pm ET, 07/01/2022
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
